UNSPSC 85815511: Introduction of blood brain barrier disruption substance into central artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of blood brain barrier disruption substance into central artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E063GN

UNSPSC 85815511 Introduction of blood brain barrier disruption substance into central artery, percutaneous approach is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code's clinical scope—a highly specialized interventional neurology procedure—does not match the recent opportunities tagged under it, which cover virtual urgent care, occupational health services, cancer registry operations, medical directorships, employee wellness platforms, opioid use disorder treatment, behavioral health services, and emergency medical staffing across multiple jurisdictions.

State and local governments are actively buying health and human services under related codes, but the code 85815511 itself captures no recent solicitations for the narrow procedure it nominally describes. The mismatch suggests either miscoding by the issuing bodies or that this procedure-specific commodity code is not in current use for state and local procurement. Business development professionals should verify the correct UNSPSC family or class code for health services opportunities before pursuing activity under this commodity; opportunities posting under it appear to reflect broader health services procurement that would be more accurately classified elsewhere in the health services taxonomy.